Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,988,979
+$648,165 QoQ
Shares Held
2,492
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#2,134
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARATHON CAPITAL MANAGEMENT holds $31,900,311 across 10 Drug Manufacturers - General names. LLY ranks #5 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
64,777 | $12,283,014 | |
| 2 | JNJ |
Johnson & Johnson
|
25,121 | $6,379,980 | |
| 3 | NVO |
Novo Nordisk A S
|
78,134 | $3,745,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,351 | $3,000,603 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
2,492 | $2,988,979 | |
| 6 | ABBV |
AbbVie Inc.
|
6,807 | $1,712,913 | |
| 7 | AMGN |
Amgen Inc
|
2,533 | $917,249 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,325 | $479,686 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,988,979 | 2,492 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,340,814 | 2,545 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,738,284 | 2,548 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,970,829 | 2,583 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,008,069 | 2,576 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,755,884 | 2,126 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,780,232 | 2,306 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,104,107 | 2,375 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,200,073 | 2,430 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,890,442 | 2,430 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,492,275 | 2,560 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,391,166 | 2,590 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,214,658 | 2,590 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $925,860 | 2,696 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $986,304 | 2,696 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $885,008 | 2,737 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $887,417 | 2,737 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $756,014 | 2,737 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $852,112 | 3,688 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $625,901 | 2,727 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $528,140 | 2,827 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $477,310 | 2,827 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $414,011 | 2,797 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $476,122 | 2,900 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $402,288 | 2,900 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||